StonvexLoading…
StonvexStonvexStonvexCore line items from MSGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.30M | $8.69M | $6.91M | $10.32M |
Operating Income | $3.25M | $-1.75M | $-16.37M | $-35.03M |
Net Income | $6.93M | $-2.75M | $-14.32M | $-35.99M |
EPS (Diluted) | $1.43 | $-0.94 | $-5.56 | $30.73 |
Total Assets | $11.97M | $6.27M | $9.76M | $18.90M |
Total Liabilities | $4.39M | $5.04M | $7.67M | $16.99M |
Cash & Equivalents | $4.99M | $859.27K | $1.68M | $979.31K |
Free Cash Flow OCF − CapEx | $4.06M | $-2.86M | $-13.68M | $-19.81M |
Shares Outstanding | 4.84M | 2.92M | 2.58M | 1.17M |